Valproate metabolites in the rat brain - Regional distribution in various brain areas

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 1, 1999, Pages 97-104

  Darius, Jörg ^a   Meyer, F P ^b   Bergstrasser E ^b   Ebermann, E ^b   Andreas, K ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b NONE

Author keywords

Brain serum distribution; Regional brain distribution; Valproate metabolites

Indexed keywords

2 PROPYL 2 PENTENOIC ACID; DRUG METABOLITE; NEUROTOXIN; VALPROIC ACID; VALPROIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TISSUE LEVEL; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; ISOMER; MEDULLA OBLONGATA; NONHUMAN; RAT; VISUAL CORTEX;

EID: 0032989640     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190017     Document Type: Article

References (23)

1. Bourgeois B.F.D. (1995) : Valproic acid - clinical use. In: Levy R.H., Mattson R.H., Meldrum B.S. (Eds). Antiepileptic drugs, 4th edn. New York: Raven, 633-639.
2. Richens A., Davidson D.L.W., Cartlidge N.E.F., Easter D.J. (1994) : A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. J. Neurol. Neurosurg. Psychiatr., 57: 682-687
3. Baillie T.A, Sheffels P.R. (1995) : Valproic acid - chemistry and biotransformation. In: Levy R.H., Mattson R.H., Meldrum B.S. (Eds). Antiepileptic drugs, 4th edn. New York: Raven, 589-604.
4. Löscher W. (1981) : Anticonvulsant activity of metabolites of valproic acid. Arch. Int. Pharmacodyn. Ther., 249: 158-163.
5. Löscher W., Nau H. (1985) : Pharmacological evaluation of various metabolites and analogues of valproic acid: anticonvulsant and toxic potencies in mice. Neuropharmacology, 24: 427-435.
6. Abbott F.S., Acheampong A.A. (1988) : Quantitative structure-anticonvulsant activity relationship of valproic acid, related carboxylic acids and tetrazoles. Neuropharmacology, 27: 287-294.
7. Elmazar M.M.A., Hauck R.-S., Nau H. (1993) : Anticonvulsant and neurotoxic activities of twelve analogues of valproic acid. J. Pharm. Sci., 82: 1255-1258.
8. Hönack D., Rundfeldt C., Löscher W. (1992) : Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats. Naunyn-Schmiedebergs Arch. Pharmacol., 345: 187-196.
9. Palaty J., Abbott F.S. (1995) : Structure-activity relationship of unsaturated analogues of valproic acid. J. Med. Chem., 38: 3398-3406.
10. Schmidt A., Darius J., Brosz M. et al. (1995) : The influence of valproic acid monotherapy on behavior and cognitive performance in children with idiopathic generalized epilepsy. Z. Kinder-Jugendpsychiatr., 23: 161-170.
11. Rohlfs A., Rundtfeldt C., Koch R., Löscher W. (1996) : A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats. J. Pharmacol. Exp. Ther., 277: 1305-1314.
12. Adkison K.D.K., Ojemann G.A., Rapport R.L., Dills R.L., Shen D.D. (1995) : Distribution of unsaturated metabolites of valproate in human and rat brain - pharmacological relevance? Epilepsia, 36: 772-782.
13. Löscher W., Fisher J.E., Nau H., Hönack D. (1989) : Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment. J. Pharmacol. Exp. Ther., 250: 1067-1078.
14. Darius J., Meyer F.P. (1996) : Concentrations of valproate metabolites under therapeutic conditions. Exp. Toxicol. Pathol., 48: 87-91.
15. Löscher W., Fisher J.E., Nau H., Hönack D. (1988) : Marked increase in anticonvulsant activity but decrease in wet-dog shake behavior during short-term treatment of amygdalakindled rats with valproic acid. Eur. J. Pharmacol., 150: 221-232.
16. Popov N., Pohle W., Lössner B. et al. (1973) : Regional distribution of RNA and protein radioactivity in the rat brain after intraventricular application of labeled precursors. Acta Biol. Med. Germ., 31: 51-62.
17. Nau H., Löscher W. (1982) : Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and γ-aminobutyric acid (GABA) metabolism in the mouse. J. Pharmacol. Exp. Ther., 220: 654-659.
18. Löscher W., Nau H. (1983) : Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment. J. Pharmacol. Exp. Ther., 226: 845-854.
19. Yu D., Gordon J.D., Zheng J. et al. (1995) : Determination of valproic acid and its metabolites using gas chromatography with mass-selective detection: application to serum and urine samples from sheep. J. Chromatogr. B Biomed. Appl., 666: 269-281.
20. Darius J. (1996) : On-column gas chromatographic-mass spectrometric assay for metabolic profiling of valproate in brain tissue and serum. J. Chromatogr. B Biomed. Appl., 682: 67-72.
21. Frey H-H., Löscher W. (1978) : Distribution of valproate across the interface between blood and cerebrospinal fluid. Neuropharmacology, 17: 637-642.
22. Adkison K.D., Shen D.D. (1996) : Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter. J. Pharmacol. Exp. Ther., 276: 1189-1200.
23. Hoeppner T.J. (1990) : The anticonvulsant valproic acid concentrates in the olfactory bulb: selective laminar localization. Brain Res., 532: 326-328.